BRIEF-POZEN's vimovo gets marketing nod in UK

Nov 12 (Reuters) - Pozen Inc: * Says was notified by Astrazeneca that marketing and pricing approval for vimovo been granted in United Kingdom * Says will receive a $25 million milestone payment within 20 days * Says confirming its 2010 year-end guidance will be net income of $21-$23 million * Says year-end cash guidance is anticipated to be $63-$65 million ((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.